chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got the vaccine and then that day I noticed that the lymph node under my left arm pit was swollen. I found online that that was normal for a week or so but at around mid February, when it was still swollen, I began to worry. I then had a herpes outbreak which tends to only occur when my immune system is struggling with something else. I then went to the doctor who tested for cancer with blood work and an ultra sound as the lymph node had become painful as well as swollen. They did not find anything but after a few more weeks, I was still experiencing pain so I went back to the doctor who wasn't sure of what could be causing the issues. I basically always have a bit of pain and swelling in that area and the pain will sometimes radiate out to my chest and arm. After 5 months I am still experiencing this pain and swelling with no answer as to what is causing it.
Upper right arm swelling, redness and pain 7 days after vaccine given. No fever.  Ice and Motrin relieves pain.
Pain at injection site, severe fatigue, feeling of passing out, drowsiness on the first day. Treated by sleeping and taking Tylenol. Second day: headache, muscle weakness and body aches on side of body injection was given. Facial weakness, weakness in right arm, headache persistent on third day as well as redness and swelling at injection site. Difficulty swallowing.
patient described pain lasting several weeks at  injection site. Large softball size red mark at  injection site, No other symptoms reported
This spontaneous report as received from a healthcare worker (office manager) reporting on behalf of the physician, refers to a patient of unknown demographics. No concurrent conditions or medical history were provided. The reporter stated that due to the fact that 2 vials of (Oka/Merck) VARIVAX injection (dose, route of administration, indication, lot# and expiry date unspecified) had an unusual appearance, a patient missed a dose on an unknown date. No concomitant medications were reported. No adverse event was reported. Additional information has been requested.
A day after 1st dose, experienced pain, right arm swollen & hot at injection site & about 10" below site. Continued x 5 days., eventually calmed down and went away.  On Jan. 23 woke up in night to arm discomfort and itching, Jan.24 arm was swollen, hot & red, about 10-12" site. It continued for 4-5 days. 2nd reaction didn't hurt as much. Also noticed HA & fatigue, light swelling of upper lip. Took Claritin D & lip swelling resolved. Phone consult with organization physician. On 1/28/21, much better, little red and hot. I feel fine. 2nd vaccine scheduled 2/12/21.
Pain in (L) shoulder. Gradual weakness (L) shoulder. Almost total atrophy of (L) supraspinatus and (L) infraspinatus muscles.
She describe the rash as red and dark; Rash everywhere all over her body; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (She describe the rash as red and dark) and RASH (Rash everywhere all over her body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 001A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) and CLOPIDOGREL for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (She describe the rash as red and dark) and RASH (Rash everywhere all over her body). At the time of the report, RASH ERYTHEMATOUS (She describe the rash as red and dark) and RASH (Rash everywhere all over her body) outcome was unknown.            No Treatment Medications were reported.
Pediatric medical records were received and reviewed concerning an 8 week old male with cleft lip and a history of jaundice, spitting up, plagiocephaly and blood bilirubin abnormal (WAES # 0708USA01488) who on 27-MAY-2008 was vaccinated with the first dose of ROTATEQ. On 29-APR-2008 the patient. Was vaccinated with hepatitis B vaccine and on 19-MAY-2008 experienced plagiocephaly and on 27-MAY-2008 experienced spit up (WAES # 0809USA01661). On 27-MAY-2008 an 8 week male infant with no known allergies was examined. The weight was 11 pounds 4.5 ounces, the length 22 1/2 inches, head circumference 15 1/2 inch, temperature 99 degrees F, pulse 128, respiratory frequency 30. Feeding problems reported as "spit up". The infant was well. The baby was vaccinated on this same day with : PREVNAR IM right thigh. ROTATEQ (660596/0211X) PO. ACTHIB IM left thigh. On 26-JUN-2008 the patient was vaccinated with:  TRIPEDIA (C2934AA) IM in left thigh. IPOL (A0492) SC/IM in right thigh. On 28-JUL-2008 a 4 months male infant with no known allergies was examined. The weight was 13 pounds 7.5 ounces, the length 25 1/4 inches, head circumference 16 1/4 inch, temperature 98.5 degrees F, pulse 1389, respiratory frequency 32. The infant was well. The baby was vaccinated on this same day with: PREVNAR (C80901) IM in the left thigh. ACTHIB (UF370AB) IM in the left thigh. On 27-AUG-2008 the patient was vaccinated with: TRIPEDIA (C2955BA) IM inn the left thigh. IPOL (A0492) SC/IM in left thigh. On 27-AUG-2008 the patient had an upper respiratory infection. No additional information is expected.
Headache, Myalgia, Fever, Localized pain; fatigue, chills Narrative:  Other Relevant History:
Pt was sitting after the covid shot for 15 minutes for the post observation. He all of a sudden was thirsty and told mom to grab water and when she was getting the water he became dizzy and fell on the floor from the chair. He injured his right side of lip where it was bleeding. He was then given water and was fine but was still feeling little dizzy. Manager called 911 and after paramedic came he was taken to the hospital. Paramedic checked the glucose level which was normal and the BP was 91/50.
Blood clot to the right side of the brain, resulting in a mini stroke.; Blood clot to the right side of the brain, resulting in a mini stroke.; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 52-year-old female patient received the second dose of bnt162b2 (PFIZER COVID VACCINE), via an unspecified route of administration administered in arm right on 23May2021 10:30 (Batch/Lot Number: EW0185) as single dose for covid-19 immunisation. Medical history included migraine and known allergies to penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included verapamil ER; valsartan; topiramate; lansoprazole. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took the first dose of bnt162b2 on 02May2021 10:00 AM on arm right (Batch/lot number: EW0176) for covid-19 immunisation. On 28May2021 06:00 PM, the patient experienced blood clot to the right side of the brain, resulting in a mini stroke. Treatment was received for the adverse event included blood thinners, clopidogrel bisulfate (PLAVIX). The adverse event result in Emergency room/department or urgent care. The patient was hospitalized for the events for 6 days, without hospitalization prolonged. The outcome of the events was not recovered. Since the vaccination, the patient had not been tested for COVID-19.
Sore arm for a couple days but felt completely fine. Exactly a week after injection,  the site became itchy, red, warm, and swollen. Used hydrocortisone cream and ice for relief but discovered heat helped more. Itchiness did not last long but redness and heat lasted a few days and spread around the injection site. Felt totally fine otherwise, no fever etc. It went away in its own in a couple of days.
a patient received a first dose of Pfizer covid vaccine and now has received his second dose as Moderna; This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received bnt162b2 (Formulation: Solution for injection; Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation; covid-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), via an unspecified route of administration from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Reporter stated that we have a situation at one of our pharmacies where a patient received a first dose of Pfizer covid vaccine and now has received his second dose as Moderna vaccine. Asking for the guidance on what we need to do. The outcome of the event was unknown.  Follow-up attempts completed. No further information expected.
Pain in her kidney; So painful that she couldn't stand or get out of bed/ Still takes her half an hour to get out of bed; Losing weight and being "skin and bones"; So much pain that she screamed; This spontaneous case was reported by a consumer and describes the occurrence of RENAL PAIN (Pain in her kidney), BEDRIDDEN (So painful that she couldn't stand or get out of bed/ Still takes her half an hour to get out of bed), WEIGHT DECREASED (Losing weight and being "skin and bones") and PAIN (So much pain that she screamed) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     The patient's past medical history included Leg amputation (Right leg). Concurrent medical conditions included Cholesterol (takes cholesterol pill), Arterial disorder (Has tiny arteries which causes blood to flow slower) and Wheelchair user (patient is wheelchair user). Concomitant products included APIXABAN (ELIQUIS) for Anticoagulant therapy.    On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Aug-2021, the patient experienced RENAL PAIN (Pain in her kidney), BEDRIDDEN (So painful that she couldn't stand or get out of bed/ Still takes her half an hour to get out of bed), WEIGHT DECREASED (Losing weight and being "skin and bones") and PAIN (So much pain that she screamed). On 01-Aug-2021, RENAL PAIN (Pain in her kidney) had resolved. On 04-Aug-2021, BEDRIDDEN (So painful that she couldn't stand or get out of bed/ Still takes her half an hour to get out of bed), WEIGHT DECREASED (Losing weight and being "skin and bones") and PAIN (So much pain that she screamed) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Aug-2021, Weight: 78 pounds (Low) 80 pounds before taking vaccine , now 78 pounds.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Additional concomitant medication includes cholesterol medication (one pill at night). Treatment information was not provided.
Initial unsolicited report received from a nurse via other company, Pfizer (Reference number- 2017116576) on 14-Apr-2017. This case involves a 65-year-old female patient who was vaccinated with a dose of TETANUS TOXOID (lot number, expiration date, route of administration, site of administration, dose and dose in series were not reported) on an unspecified date. The medical history and the concomitant medications were not reported. On 07-Feb-2017, following the vaccination, the patient developed allergy (rash and site swelling). The laboratory test and the corrective treatment was not reported. The outcome of the events was not reported. List of the documents held by sender: none.
Temp 101.9; injection site redness; Initial information received on 18-Jul-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a male patient who experienced pyrexia and vaccination site erythema, while he received vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, (at the age of 15 months old) the patient received a dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious temp 101.9 (pyrexia) and injection site redness (vaccination site erythema) (unknown latency) following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE.  Final diagnosis was vaccination site erythema and pyrexia.   It was not reported if the patient received a corrective treatment.  The patient outcome was reported as unknown for vaccination site erythema and pyrexia.  Information on the batch number was requested.  List of document held by sender: none.
Initial unsolicited report received from a Physician on 06-Dec-2017. This case involves five-year-old male patient who was vaccinated once with a 0.5 ml dose of  IPOL (batch number- M1231C) and once with 0.5 ml DTAP (batch number- C5041BA) (expiry date, Dose, Dose in series, and site of administration were not reported for both the vaccines) intramuscularly on an unknown date of 2016. Medical history and concomitant medications were not reported. On an unspecified date of 2013, previously patient was vaccinated with INFLUENZA VACCINE (batch no: V4488EA).On an unknown date, following the vaccination, the patient had hives and facial swelling. Laboratory investigations and corrective treatment were not reported. Outcome of the events were unknown. List of documents held by sender: none.
COVID-19; COVID-19; Pfizer / BioNTech, Dose Number: 1, 2 ; Moderna, Dose Number: 3-5; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 64-year-old male patient received BNT162b2 (BNT162B2), on 23Mar2021 as dose 1, single (Lot number: Er8727), in left leg and on 14Apr2021 as dose 2, single (Lot number: Ew0151) at the age of 62 years, in left arm for COVID-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 11Nov2021 as dose 3 (booster), single (Lot number: 065F21A), in left arm, on 09Apr2022 as dose 4 (booster), single (Lot number: 016J21-2A), in left arm and on 06Sep2022 as dose 5 (booster), single (Lot number: AS7144B), in left arm for COVID-19 immunisation. The patient's relevant medical history included: "Type 1 diabetes" (unspecified if ongoing); "Hashimoto's thyroiditis" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Levofloxacin hemihydrate, reaction(s): "Known allergies: Levofloxacin Hemihydrate". The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 11Nov2021, outcome "not recovered", described as "Pfizer / BioNTech, Dose Number: 1, 2 ; Moderna, Dose Number: 3-5"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19; Positive, notes: Return of COVID symptoms 4 days after completing Paxlovid treatment and a positive COVID test. Therapeutic measures were taken as a result of vaccination failure, COVID-19 with Paxlovid from 17Feb2023 to 22Feb2023.
At the site of injection, I developed a 6cm ovoid erythematous rash. It is slightly raised and pruritic. It feels warm and is redder around the perimeter than in the center.
MEMBER REPORTED TO SICK CALL C/O NOSE BLEED X 2 DAYS, WITH RASH AROUND HIS WAIST LINE, CLINIC ON BASE DID BLOOD TEST.  2/5/09 Received clinic medical records of 1/20/09. FINAL DX: critically low platelet count Records reveal patient experienced epistaxis several times, rash around waist. Had GI illness 1 week prior that resolved. Sent to ER when labs returned.  LABS: plts 2000(L)./ss   2/27/09 Received hospital medical records of 1/20-1/27/2009. FINAL DX: thrombocytopenia secondary to ITP; epistaxis; nausea. Records reveal patient experienced nosebleeds, petechial rash & intermittent confusion x 4 days. Had stomach virus few weeks prior.  Heme consult done.  Tx w/IV steroids & plt transfusion w/min improvement.  Tx w/IVIG & improved.  D/c to hoome w/heme f/u & serial labs.
A nurse reported pt had vax & on the same day, developed cellulitis. Pt was hospitalized & tx'd with IV Unasyn; 3 grams every 6 hrs. This is 1 of 2 pts from this facility who developed cellulitis after this vax;other was non-serious.
Immediately after injection, the injection site began itching severely.  Injection site became red, hot, swollen and sore.  There was a 3-4 inch raised knot at the injection site that lasted 4-6 days.  She also complains of fatigue since receiving the shot.  On 10/8 she developed low-grade fever that has continued intermitantly since.  She complains of ongoing fatigue, headache, muscle aches that started in the arm, shoulder, neck and back of the injection site side and then progressed to general body aches.  In early November. patient reported she is still experiencing fatigue, back pain, alot more SOB than prior to the shot, and constant joint pain of varying degrees.  Still has low-grade fever at times.
This spontaneous report received from a patient concerned a 55 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included psoriatic arthritis. The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: UNKNOWN) dose was not reported at 1 total frequency, administered on APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Non-company suspect drugs included: adalimumab (solution for injection in pre-filled pen, subcutaneous, batch number: 1133817 expiry: UNKNOWN) dose was not reported, 1 time every 1 total, therapy dates were not reported for psoriatic arthritis. No concomitant medications were reported. On an unspecified date in 2021, the patient experienced bloody stool and diarrhea. On an unspecified date, the subject experienced sore mouth, and sore gums. The action taken with COVID-19 vaccine ad26.cov2.s was not applicable and for adalimumab was not reported. The outcome of the bloody stool, diarrhea, sore mouth and sore gums was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210601168-COVID-19 VACCINE AD26.COV2.S- Bloody Stool. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 25-FEB-2014, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB 5 microgram/0.5 mL (lot # H017304, expiration date 05-DEC-2015, dose and route were unknown). No adverse effects were reported. The vaccine was exposed to temperature excursion once. The total cumulative excursion time was 72 hours. The lowest recorded temperature was 32 Celsius degree. The storage criteria of the vaccine and the type of excursion were refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
but that he developed a red spot "smaller than a baseball but larger than a golf ball" at the site of injec; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (but that he developed a red spot "smaller than a baseball but larger than a golf ball" at the site of injec) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (but that he developed a red spot "smaller than a baseball but larger than a golf ball" at the site of injec). At the time of the report, VACCINATION SITE ERYTHEMA (but that he developed a red spot "smaller than a baseball but larger than a golf ball" at the site of injec) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication was reported. No concomitant medication was reported.   This case was linked to MOD-2021-330240.
I received the Covid booster shot at 9/30/2021. , After that, I experienced headaches the next 2 weeks. On Saturday 8, a week after Covid booster, I had a very bad day. I was sweating a lot and I got dehydrated. I am almost pass out. I had short memory lost. After that day, it has been very difficult to feel completely recovered. I ended up in the emergency room on Sunday 9. I was with headaches , dizziness and chills. Today, I am doing better but not totally recovered. I am still having headaches.
MMR given 2/18/11 when pt went to Dr. for office follow-up visit 3/24/11. The area of vaccine injection was red & swollen.
Painful rash appeared at injection site within 24 hours of vaccine.  The rash is likely covid arm.  It is still painful, itchy and swollen today.
Headache; Sore throat; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  An 18 year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in left arm, administration date 22Mar2021 16:00 (Batch/Lot number: unknown) at the age of 18 years as dose number unknown, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: HEADACHE (non-serious) with onset 23Mar2021, outcome "not recovered", described as "Headache"; OROPHARYNGEAL PAIN (non-serious) with onset 23Mar2021, outcome "not recovered", described as "Sore throat". Therapeutic measures were taken as a result of headache, oropharyngeal pain. Additional information: Treatment included unspecified oral analgesic. The patient had no known allergies (NKA). Prior to vaccination, the patient has not been diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The events did not result to doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
I had a sore arm after receiving the vaccine for about a day. On 03/04/2023, I was diagnosed with a urinary tract infection. I went to the hospital for one day due to not being able to pee. I had a blockage too. I was put on a foley catheter for about two months. I am scheduled for a procedure on Friday with a laser procedure.